Relying on everything from artificial intelligence to Bluetooth technology, the nine startups in the fourth class of the accelerator are working to solve problems related to patient consent, medical equipment tracking and more.
The Cedars-Sinai accelerator, which is powered by Techstars, announced its third cohort of startups this fall. Now, the 10 selected companies have unveiled deals and partnerships with various players in the healthcare space.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Whittled down from roughly 600 applicants, the goals of the 10 companies in the third cohort include improving the patient experience, offering more personalized care plans for cancer treatment, triaging patients faster and making blood sample collection less painful.
Cedars-Sinai Accelerator, a collaboration between the Los Angeles-based health system and Techstars, has named seven health IT companies taking part in its second cohort.
There were a diverse set of healthcare startups at CONVERGE this year from medical device startup Inscope Technologies to contextualizing data from social media apps to gain personal insights on health.
Cedars-Sinai's first healthcare startup accelerator with Techstars includes 11 startups, whittled down from 500 applicants.
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
Darren Dworkin said it has set up a dedicated facility adjacent to the Cedars-Sinai campus to house the accelerator.
The accelerator seeks "companies with pioneering ideas that improve quality, safety and efficiency of health and healthcare delivery," Techstars managing partner David Brown wrote in his blog.
Techstars managing director offers link to venture capital fund listings.
https://youtube.com/watch?v=EjIdEVmpYjI A mobile health accelerator run at Sprint headquarters in Kansas and managed by TechStars assembled its second class of startups. Most of the problems the class members are bent on solving are consumer-focused tasks such as a thermometer to improve fertility, a smart water bottle to keep users hydrated and an air purifiers. Triomi’s […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
As Sprint gears up for the second class of its mobile health accelerator program in Kansas City, it’s added a clutch of hospital and health system partners, according to a company statement. Although it had healthcare partners for its inaugural class last year, the idea is that more formalized relationships will make it easier for […]
Techstars has made an agreement with the MayoClinic to provide a two week residency program as part of an initiative to equip graduates of its program with more practical experience of working directly with corporate partners, according to a statement on CEO and co-founder David Cohen’s blog. It expects to announce additional partners in the […]
Sprint (NYSE: S) is making a big push for mobile health innovation in the Midwest with its Sprint Mobile Health accelerator in Kansas City. It’s extended the applicant deadline to January 6. The accelerator is powered by TechStars. It is seeking 10 teams of entrepreneurs who have either developed their own mobile health technology or […]